What is the level of liabilities of Sunmax Biotechnology Co this year?
Sunmax Biotechnology Co has a debt balance of 732.99 M TWD this year.
Sunmax Biotechnology Co Liabilities 2024
Sunmax Biotechnology Co Liabilities
732.99 M TWD
Sunmax Biotechnology Co Dividend yield
2.91 %
Ticker
4728.TWO
ISIN
TW0004728001
In 2024, Sunmax Biotechnology Co's total liabilities amounted to 732.99 M TWD, a 56.62% difference from the 468 M TWD total liabilities in the previous year.
Sunmax Biotechnology Co Aktienanalyse
What does Sunmax Biotechnology Co do?
Sunmax Biotechnology Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Sunmax Biotechnology Co's Liabilities
Sunmax Biotechnology Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sunmax Biotechnology Co's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Sunmax Biotechnology Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Sunmax Biotechnology Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Sunmax Biotechnology Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Sunmax Biotechnology Co Stock
What were the liabilities of Sunmax Biotechnology Co compared to the previous year?
The liabilities of Sunmax Biotechnology Co have increased by 56.62% increased compared to the previous year.
What are the consequences of high debt for investors of Sunmax Biotechnology Co?
High liabilities can pose a risk for investors of Sunmax Biotechnology Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Sunmax Biotechnology Co?
Low liabilities mean that Sunmax Biotechnology Co has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Sunmax Biotechnology Co affect the company?
An increase in liabilities of Sunmax Biotechnology Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Sunmax Biotechnology Co affect the company?
A decrease in the liabilities of Sunmax Biotechnology Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Sunmax Biotechnology Co?
Some factors that can influence the liabilities of Sunmax Biotechnology Co include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Sunmax Biotechnology Co so important for investors?
The liabilities of Sunmax Biotechnology Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Sunmax Biotechnology Co take to modify the liabilities?
To change its liabilities, Sunmax Biotechnology Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Sunmax Biotechnology Co pay?
Over the past 12 months, Sunmax Biotechnology Co paid a dividend of 9.5 TWD . This corresponds to a dividend yield of about 2.91 %. For the coming 12 months, Sunmax Biotechnology Co is expected to pay a dividend of 9.5 TWD.
What is the dividend yield of Sunmax Biotechnology Co?
The current dividend yield of Sunmax Biotechnology Co is 2.91 %.
When does Sunmax Biotechnology Co pay dividends?
Sunmax Biotechnology Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sunmax Biotechnology Co?
Sunmax Biotechnology Co paid dividends every year for the past 2 years.
What is the dividend of Sunmax Biotechnology Co?
For the upcoming 12 months, dividends amounting to 9.5 TWD are expected. This corresponds to a dividend yield of 2.91 %.
In which sector is Sunmax Biotechnology Co located?
Sunmax Biotechnology Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sunmax Biotechnology Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sunmax Biotechnology Co from 8/8/2023 amounting to 9.5 TWD, you needed to have the stock in your portfolio before the ex-date on 7/18/2023.
When did Sunmax Biotechnology Co pay the last dividend?
The last dividend was paid out on 8/8/2023.
What was the dividend of Sunmax Biotechnology Co in the year 2023?
In the year 2023, Sunmax Biotechnology Co distributed 4.4 TWD as dividends.
In which currency does Sunmax Biotechnology Co pay out the dividend?
The dividends of Sunmax Biotechnology Co are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sunmax Biotechnology Co
Our stock analysis for Sunmax Biotechnology Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sunmax Biotechnology Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Sunmax Biotechnology Co Revenue
- Sunmax Biotechnology Co Net Income
- Sunmax Biotechnology Co P/E
- Sunmax Biotechnology Co P/S
- Sunmax Biotechnology Co EBIT
- Sunmax Biotechnology Co Dividend
- Sunmax Biotechnology Co Stocks
- Sunmax Biotechnology Co Market capitalization
- Sunmax Biotechnology Co Debt
- Sunmax Biotechnology Co Liabilities
- Sunmax Biotechnology Co Equity
- Sunmax Biotechnology Co AAQS
- Sunmax Biotechnology Co Employees
- Sunmax Biotechnology Co ROE
- Sunmax Biotechnology Co ROA
- Sunmax Biotechnology Co ROCE